TickerFacts.

Connect Biopharma Holdings Ltd (CNTB): Revenue

Annual figures by period end, from SEC filings.

$64.0K
Year ended 2025-12-31
$2.95M
Trailing 12 months to 2026-06-30
$26.03M2023-12-31: $02024-12-31: $26.03M2025-12-31: $64.0K$64.0K
2023-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$64.0K-99.8%2026-03-31, From 2025-01-01
2024-12-31$26.03Mn/a2026-03-31, From 2024-01-01
2023-12-31$0n/a2025-03-31, From 2023-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Connect Biopharma Holdings Ltd (CNTB)2025-12-31$64.0K-99.8%
Inovio Pharmaceuticals, Inc. (INO)2025-12-31$65.3K-70.0%
Avalo Therapeutics, Inc. (AVTX)2025-12-31$59.0K-86.6%
Silo Pharma, Inc. (SILO)2025-12-31$72.1K0.0%
HCW Biologics Inc. (HCWB)2025-12-31$54.2K-97.9%
Incannex Healthcare Inc. (IXHL)2025-06-30$86.0K+616.7%
Actinium Pharmaceuticals, Inc. (ATNM)2025-12-31$90.0Kn/a
Altimmune, Inc. (ALT)2025-12-31$41.0K+105.0%
iBio, Inc. (IBIO)2026-06-30$100.0K-75.0%

Compare CNTB, INO, AVTX, SILO side by side · Screen every company in Pharmaceutical Preparations ↗